The need for non- or minimally-invasive biomonitoring strategies and the development of pharmacokinetic/pharmacodynamic models for quantification
- PMID: 35978611
- PMCID: PMC9380408
- DOI: 10.1016/j.cotox.2017.03.003
The need for non- or minimally-invasive biomonitoring strategies and the development of pharmacokinetic/pharmacodynamic models for quantification
Abstract
Advancements in Exposure Science involving the development and deployment of biomarkers of exposure and biological response are anticipated to significantly (and positively) influence health outcomes associated with occupational, environmental and clinical exposure to chemicals/drugs. To achieve this vision, innovative strategies are needed to develop multiplex sensor platforms capable of quantifying individual and mixed exposures (i.e. systemic dose) by measuring biomarkers of dose and biological response in readily obtainable (non-invasive) biofluids. Secondly, the use of saliva (alternative to blood) for biomonitoring coupled with the ability to rapidly analyze multiple samples in real-time offers an innovative opportunity to revolutionize biomonitoring assessments. In this regard, the timing and number of samples taken for biomonitoring will not be limited as is currently the case. In addition, real-time analysis will facilitate identification of work practices or conditions that are contributing to increased exposures and will make possible a more rapid and successful intervention strategy. The initial development and application of computational models for evaluation of saliva/blood analyte concentration at anticipated exposure levels represents an important opportunity to establish the limits of quantification and robustness of multiplex sensor systems by exploiting a unique computational modeling framework. The use of these pharmacokinetic models will also enable prediction of an exposure dose based on the saliva/blood measurement. This novel strategy will result in a more accurate prediction of exposures and, once validated, can be employed to assess dosimetry to a broad range of chemicals in support of biomonitoring and epidemiology studies.
Keywords: Biomarkers; Computational modeling; Non-invasive; Sensors.
Conflict of interest statement
Conflict of interest The authors have nothing to disclose.
Figures
Similar articles
-
Noninvasive biomonitoring approaches to determine dosimetry and risk following acute chemical exposure: analysis of lead or organophosphate insecticide in saliva.J Toxicol Environ Health A. 2004 Apr 23-May 28;67(8-10):635-50. doi: 10.1080/15287390490428035. J Toxicol Environ Health A. 2004. PMID: 15192859 Review.
-
Development of a non-invasive biomonitoring approach to determine exposure to the organophosphorus insecticide chlorpyrifos in rat saliva.Toxicol Appl Pharmacol. 2007 Mar;219(2-3):217-25. doi: 10.1016/j.taap.2006.10.002. Epub 2006 Oct 6. Toxicol Appl Pharmacol. 2007. PMID: 17118418
-
Towards a systematic use of effect biomarkers in population and occupational biomonitoring.Environ Int. 2021 Jan;146:106257. doi: 10.1016/j.envint.2020.106257. Epub 2020 Dec 15. Environ Int. 2021. PMID: 33395925 Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Dietary glycation compounds - implications for human health.Crit Rev Toxicol. 2024 Sep;54(8):485-617. doi: 10.1080/10408444.2024.2362985. Epub 2024 Aug 16. Crit Rev Toxicol. 2024. PMID: 39150724
References
-
- National Research Council (NRC) toxicity testing in the 21st century: a vision and a strategy. Washington, D.C: National Academy Press; 2007.
-
- Liu G, et al.: Enzyme nanoparticles-based electronic biosensor. Chem Commun (Camb) 2005;(27):3481–3483. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources